Surgical Treatment of Local Prosthetic Graft Infection with Fresh Arterial Homograft: Report of Four Cases  by Pupka, A et al.
SHORT REPORT
Surgical Treatment of Local Prosthetic Graft Infection with
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Poniatowskiego 2, 50-326 Wrocław, Poland
Infection following vascular operations, particularly after synthetic prosthetic graft implantation, remains a serious
complication of reconstructive vascular surgery. In this paper, four cases of bifurcated graft infection limited to the distal part
of one of the branches are presented. Because of the unsatisfactory results of conventional treatment, the patients underwent
in situ replacement of the infected distal part of the prosthesis branch with fresh arterial homograft. Follow-up revealed
complete remission of infection. The use of arterial homograft can be limited to the replacement of infected segment of
prosthesis.
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Introduction
The routine use of vascular prosthetic grafts has
resulted in an increase in the number of surgically
treated patients as well as an increase in the number of
infectious complications due to the use of synthetic
materials.1 Irrespective of the surgical approach and
type of antibiotic prophylaxis, vascular graft infection
occurs in 1–3% of patients and it is a frequent cause of
morbidity and mortality.1 – 3 Surgical treatment con-
sists of the complete removal of the infected vascular
graft with the preservation of limb circulation.1,2 The
poor results of conventional therapy have contributed
to the employment of arterial grafts harvested from
brain-dead organ donors during multiple organ
procurement.1,3 – 5 The replacement of the vascular
graft, particularly of the bifurcated one with the
arterial homograft is technically very difficult, pro-
longed and risky.4,6
In this study the treatment of four cases of local
infection of an aorto-bifemoral prosthesis with the use
of the arterial homograft is presented.
Case Reports
Four men between the ages of 45 and 60
(mean ¼ 54.25) were treated for the local infection of
a bifurcated prosthesis with the use of arterial
homograft between 2000 and 2002 (Table 1). The
patients were admitted to our surgical ward because of
purulent fistulæ in the inguinal region and/or the
rupture of the anastomosis between the prosthesis and
the femoral artery which resulted in haemorrhage—V
degree on the Samson scale.7 The treatment of sup-
puration consisted of local excision of infected tissues,
debridement with the use of betadine solution, long-
term irrigation and the local application of gentamicin-
soaked collagen sponges. Additionally, antibiotic
treatment based on culture and sensitivities was
administered. Unfortunately, local excision and debride-
ment were unsuccessful, so all of these patients were
readmitted after 3–6 months (mean ¼ 4.75), because
of rupture of a distal anastomosis. Duplex ultrasound
and scintigraphy revealed infection of one limb of the
aorto-bifemoral prosthesis between the distal anasto-
mosis and the inguinal ligament. Perigraft fluid
collection and migration of Technetium 99m-labelled
leukocytes to the graft branch were observed. Bac-
teriological examination revealed methicillin-resistant
Staphylococcus aureus (MRSA) and Staphylococcus
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epidermidis, both Vancomycin sensitive. All patients
had MRSA. No features of generalised prosthesis
infection were seen. In this situation it was decided to
remove just the infected segment of the vascular
prosthesis and to replace it with an arterial homograft
harvested during multiorgan procurement. All the
excised grafts were cultured and bacteriological
results were the same as these obtained from the
examination of four infected tissues. In all cases
arterial allografts were implanted. AB0 compatibility
and negative cross-match between the recipient’s
serum and donor’s lymphocytes were obligatory.
The common and the external iliac arteries were
harvested with surrounding tissues with an adequate
safety margin for the procedure of homograft implan-
tation. The allografts were stored in University of
Wisconsin solution at 4 8C with antibiotics (Vancomycin,
Lincomycin). The homografts were implanted in place
of the removed infected segment of the bifurcated
prosthesis within 17–21 h (mean ¼ 19.25) after pro-
curement. The harvested arterial by-pass was dis-
sected atraumatically before implantation. The
homograft was sutured in using two end-to-end
anastomoses, proximally retroperitoneally to the
remaining part of the branch of bifurcated graft
above the inguinal ligament, distally to the deep
femoral artery (Figs. 1 and 2). Diagnostic monitoring of
infection (e.g. duplex sonography, scintigraphy exam-
ination) was performed during the follow-up period
on the seventh, 21st day and in the first, third, sixth,
12th and 16th month after the surgery. This revealed
the remission of infection (Table 1). Duplex ultrasound
showed no fluid collections around implanted allo-
graft and the remaining bifurcated graft. White cell
scanning showed regression of Technetium 99m-
labelled leukocyte migration to the place of the
graft replacement. In all of the cases antibiotic therapy
was continued for 8 weeks following homograft
implantation. In the postoperative follow-up no
blood flow disturbances in the lower extremities
were observed.
Discussion
Vascular graft infection frequently leads to significant
morbidity and mortality. The management of infection
using locally applied antibiotic solutions is rarely a
satisfactory solution.2 Eventually graft infection
causes the rupture of anastomoses which frequently
leads to death.1,2 The patients mentioned above were
treated initially with long-term irrigation and locally
applied antibiotics with no success. The infection
caused the rupture of anastomoses that resulted in
haemorrhage.1,2 Imaging (duplex ultrasound and
scintigraphy) and bacteriology confirmed the infec-
tion.1,2,8,11 Scintigraphy localises the infection.8,11 The
whole prosthesis is usually involved in the infection
process. The complete removal of the synthetic graft
followed by extraanatomic by-pass and the replace-
ment of the infected graft with an antibiotic-bonded
or silver-coated vascular prosthesis or with auto-
logous or homologous grafts are most often used
as therapeutic methods.1 – 3,5,9 – 12 The biological
materials which are the most frequently used are
patient’s own veins or arteries harvested from brain-
dead organ donors stored by deep freezing or cold
ischemia.1,3 – 6,13 The in situ replacement of an infected
vascular prosthesis with arterial homograft material
Fig. 1. Infected branch of bifurcated prosthesis.
Table 1. Characteristic of patients












1 45 Arteriosclerosis 3 years 3 months Diabetes 16 months
2 60 Arteriosclerosis 7 years 6 months Necrosis of toes 16 months
3 58 Arteriosclerosis 2 years 4 months Necrosis of toes 12 months
4 54 Aneurysm 3 years 6 months - 16 months
A. Pupka et al.82
EJVES Extra, 2004
can lead to eradication of the infection. Additionally,
only biological material is able to heal well in the
presence of infection.3 – 6,12,13 Homografts harvested
during multiple organ procurement and stored as
above were implanted in both cases.3 – 5,13 The employ-
ment of this method is only possible after excluding
cross-reaction between donor and recipient.3,5 Imag-
ing, especially using scintigraphy with Technetium
99m-labelled leukocytes, revealed the local infection of
bifurcated graft limited to the distal part of one of its
branches.8 In this situation we decided to replace only
the infected segment of the prosthesis with fresh
arterial homograft. We have found no similar cases in
the surgical literature. Limited surgery as opposed to
replacement of the whole aorto-bifemoral prosthesis
with an allograft, reduced the probability of severe
postoperative complications. Scintigraphy allowed us
to monitor the regression of the infection.11 Duplex
ultrasound revealed no allograft pathology during the
follow-up period. The most frequently described
complications are graft aneurysm and homograft
thrombosis.3,9
Conclusion
The use of arterial homograft can be limited to the
replacement of infected segment of prosthesis with
arterial homograft, but this therapeutic method
requires further investigations and scrupulous
observations.
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Fig. 2. Arterial homograft anastomosed with right branch of
bifurcated prosthesis.
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